Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation.

about

Pretreatment with intravenous amiodarone improves the efficacy of ibutilide treatment on cardioversion rate and maintenance time of sinus rhythm in patients with persistent atrial fibrillation.

Item

http://www.wikidata.org/entity/Q42051574

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@en

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@nl

type

Item

label

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@en

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@nl

prefLabel

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@en

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@nl

P1476

Pretreatment with intravenous ...... ersistent atrial fibrillation.

@en

P2093

Chunlin Gong

http://www.w3.org/2001/XMLSchema#string

Hao Wang

http://www.w3.org/2001/XMLSchema#string

Hong Yao

http://www.w3.org/2001/XMLSchema#string

Rongsheng Xie

http://www.w3.org/2001/XMLSchema#string

Ye Wang

http://www.w3.org/2001/XMLSchema#string

Yingfang Shang

http://www.w3.org/2001/XMLSchema#string

Zengxiang Dong

http://www.w3.org/2001/XMLSchema#string

Zhaoguang Liang

http://www.w3.org/2001/XMLSchema#string

Zhuangzhuang Miao

http://www.w3.org/2001/XMLSchema#string

P2860

Antiarrhythmic drugs for maintaining sinus rhythm after cardioversion of atrial fibrillation: a systematic review of randomized controlled trials.

Efficacy and safety of repeated intravenous doses of ibutilide for rapid conversion of atrial flutter or fibrillation. Ibutilide Repeat Dose Study Investigators.

Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias.

Superiority of ibutilide (a new class III agent) over DL-sotalol in converting atrial flutter and atrial fibrillation. The Ibutilide/Sotalol Comparator Study Group.

Propafenone added to ibutilide increases conversion rates of persistent atrial fibrillation.

Mechanisms of termination and prevention of atrial fibrillation by drug therapy.

Antiarrhythmic drugs for the maintenance of sinus rhythm: risks and benefits.

Drug induced lung disease--amiodarone in focus.

Ibutilide, a methanesulfonanilide antiarrhythmic, is a potent blocker of the rapidly activating delayed rectifier K+ current (IKr) in AT-1 cells. Concentration-, time-, voltage-, and use-dependent effects.

Acute amiodarone pulmonary toxicity following lung resection.

P304

686-690

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/BR.2017.896

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-04-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28584642

http://www.w3.org/2001/XMLSchema#string

P932

5449953

http://www.w3.org/2001/XMLSchema#string